Advertisement
Canada markets open in 2 hours 16 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7314
    +0.0016 (+0.22%)
     

  • CRUDE OIL

    82.80
    -0.01 (-0.01%)
     

  • Bitcoin CAD

    87,138.79
    -3,744.40 (-4.12%)
     

  • CMC Crypto 200

    1,349.61
    -32.96 (-2.38%)
     

  • GOLD FUTURES

    2,341.30
    +2.90 (+0.12%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,481.75
    -182.75 (-1.03%)
     

  • VOLATILITY

    16.23
    +0.26 (+1.63%)
     

  • FTSE

    8,087.58
    +47.20 (+0.59%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6814
    -0.0005 (-0.07%)
     

Wall Street Fundamentals Releases New In-Depth Stock Reports on MAKO, RMD, STXS and ZMH

ACCESSWIRE

The Patient Protection and Affordable Care Act, also known as Obamacare, can be seen as a double-edged sword for the Medical Device Industry. On one hand it imposes a 2.3% medical-device excise tax on gross sales of taxable devices reducing profits for companies across the board, but on the other it is expected to create a new market of millions of previously uninsured Americans. For the most part, larger companies have done an admirable job of absorbing the tax through restructuring efforts. "Where it is a little more onerous is with the smaller companies," said Matt Taylor, a medical device analyst with Barclays. "It is a tax on sales, if you're a growing company that isn't making a profit, that could be harder to offset."

MAKO Surgical Corp. (NASDAQ:MAKO - News) shares traded in the range of $13.90 to $14.48 Tuesday before settling to close at $14.31, an increase of 1.85 percent. The stock appears to be facing some resistance at $15.64 with some support at the $14.26 and $14.00 levels. Shares of MAKO Surgical have gained approximately 11.0 percent in 2013.

More information on MAKO Surgical and access to the free equity report can be found at:
www.WallStreetFundamentals.com/MAKO

ResMed Inc. (NYSE:RMD - News) shares traded in the range of $49.29 to $49.78 Tuesday before settling to close at $49.32, a decrease of 0.38 percent. The stock appears to be facing some resistance at the $50.22 and $51.17 levels with some support at $48.64. Shares of ResMed have gained approximately 18.0 percent in 2013.

ADVERTISEMENT

More information on ResMed and access to the free equity report can be found at:
www.WallStreetFundamentals.com/RMD

Stereotaxis Inc. (NASDAQ:STXS - News) shares traded in the range of $3.62 to $3.95 Tuesday before settling to close at $3.73, an increase of 2.75 percent. The stock appears to be facing some resistance at the $4.20 and $4.72 levels with some support at $3.00. Shares of Stereotaxis have gained approximately 46.0 percent in 2013.

More information on Stereotaxis and access to the free equity report can be found at:
www.WallStreetFundamentals.com/STXS

Zimmer Holdings, Inc. (NYSE:ZMH - News) shares traded in the range of $79.35 to $80.21 Tuesday before settling to close at $79.85, an increase of 0.28 percent. The stock appears to be facing some resistance at the $80.50 and $83.63 levels with some support at $78.59. Shares of Zimmer have gained approximately 20.0 percent in 2013.

More information on Zimmer and access to the free equity report can be found at:
www.WallStreetFundamentals.com/ZMH

Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.

Activate your always free membership by signing up at www.WallStreetFundamentals.com today.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Wall Street Fundamentals
Website: www.WallStreetFundamentals.com
Email: editor@wallstreetfundamentals.com